Overview
Diversified Botanics builds and scales botanical wellness brands by combining research-driven product development with scalable manufacturing across performance, recovery, mood, cognition, and beyond. Its process starts with scientific validation and regulatory planning, followed by formulation and manufacturing in cGMP facilities, with AI-optimized operations to speed development and ensure quality. Its approach blends rigorous science, formal manufacturing standards, data-driven supply chains, and an integrated platform that covers development, production, and brand expansion across multiple categories, all under transparent practices. The company’s goal is to shape the future of botanicals by delivering credible, regulation-ready, clinically informed products at scale and building the fastest-growing, trusted brands in the botanical wellness space.
Work here?Claim your company
Simplify's take
What believers are saying
- Court approval on October 20, 2026 let Diversified keep operating as debtor-in-possession.
- The Missouri manufacturing contract preserves product supply after Utah production stopped July 31, 2026.
- November 10, 2026 hearings could accelerate lease exits and restore a leaner cost structure.
What critics are saying
- Chapter 11 on October 7, 2026 exposes an existential liquidity and creditor-control threat.
- Ryan Niddel said revenue fell from $98 million to $30 million annualized by October 2026.
- Utah kratom restrictions forced manufacturing shutdowns, lease rejections, and Missouri outsourcing by November 2026.
What makes Diversified Botanics unique
- MIT45 Gold, Golden Monk, Kavaa, and I Am Uprising span multiple botanical categories.
- Diversified Botanics owns a 200,000-square-foot Draper campus and in-house manufacturing heritage.
- The company built a kratom brand moat around proprietary extracts and functional wellness positioning.
Help us improve and share your feedback! Did you find this helpful?